Page last updated: 2024-10-30

losartan and Fever

losartan has been researched along with Fever in 3 studies

Losartan: An antagonist of ANGIOTENSIN TYPE 1 RECEPTOR with antihypertensive activity due to the reduced pressor effect of ANGIOTENSIN II.
losartan : A biphenylyltetrazole where a 1,1'-biphenyl group is attached at the 5-position and has an additional trisubstituted imidazol-1-ylmethyl group at the 4'-position

Fever: An abnormal elevation of body temperature, usually as a result of a pathologic process.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's1 (33.33)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Orentas, M1
Patel, N1
Rodby, R1
Hassan, S1
Chen, F1
Liu, F1
Badoer, E1
Shimizu, H1
Miyoshi, M1
Matsumoto, K1
Goto, O1
Imoto, T1
Watanabe, T1

Reviews

1 review available for losartan and Fever

ArticleYear
The association between adult-onset Still's disease and collapsing glomerulopathy: a case report.
    Journal of medical case reports, 2022, Oct-14, Volume: 16, Issue:1

    Topics: Adolescent; Adult; Cyclosporine; Female; Fever; Humans; Kidney Diseases; Kidney Failure, Chronic; Lo

2022

Other Studies

2 other studies available for losartan and Fever

ArticleYear
AT1 receptors in the paraventricular nucleus mediate the hyperthermia-induced reflex reduction of renal blood flow in rats.
    American journal of physiology. Regulatory, integrative and comparative physiology, 2011, Volume: 300, Issue:2

    Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Blood Pressure; Body Temperature; Fever; Heart Rat

2011
The effect of central injection of angiotensin-converting enzyme inhibitor and the angiotensin type 1 receptor antagonist on the induction by lipopolysaccharide of fever and brain interleukin-1beta response in rats.
    The Journal of pharmacology and experimental therapeutics, 2004, Volume: 308, Issue:3

    Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Angiotensins; Ani

2004